12月3日，云天化（600096.SH）发布公告称，其全资子公司云南磷化集团有限公司根据税务部门要求 开展涉税自查，需补缴2022年至2025年10月期间的资源税及滞纳金，合计3.86亿元。 财务数据显示，2025年前三季度，云天化实现营业收入375.99亿元，归母净利润47.29亿元。 （文章来源：中国经营报） 公告显示，此次应补缴资源税金额为2.93亿元，滞纳金9264.55万元。根据相关会计准则，该补缴事项不 属于前期会计差错，不涉及前期财务数据追溯调整，相关款项将计入2025年当期损益，预计减少归属于 上市公司股东的净利润3.42亿元，具体影响以年度审计报告为准。 云天化在公告中表示，本次补缴税款事项不会对日常生产经营活动产生重大影响。 ...

Group 1 - Dongfang Electric announced that three executives plan to reduce their holdings by a total of no more than 30,000 shares due to personal financial needs [1] - Yahu Pharmaceutical's APL-1401 clinical trial data was presented at the 19th European Colorectal Congress, indicating progress in treating moderate to severe ulcerative colitis [1] - Guizhou Bai Ling's actual controller is under investigation by the China Securities Regulatory Commission for insider trading and information disclosure violations [3] Group 2 - Bairen Medical's ePTFE pericardial membrane product has been approved for registration, ending the reliance on imports for this product in the domestic market [4] - Qianxin received approval for a total of 2 billion yuan in technology innovation bonds, with plans to issue medium-term notes and short-term financing bonds [6] - Tengjing Technology's shareholder plans to reduce holdings by no more than 1.96% of the company's shares [7] Group 3 - Yuntianhua's subsidiary is required to pay 386 million yuan in overdue taxes and penalties, which will impact the company's net profit for 2025 [8] - Jianyou Pharmaceutical's propofol emulsion injection has received FDA approval in the United States [9] - Suzhou Gaoxin successfully acquired land use rights for a residential project for 360 million yuan [9] Group 4 - Chalco International's subsidiary won a bid for a 3.03 billion yuan electrolytic aluminum project [11] - Tai Long Pharmaceutical's stock will continue to be suspended due to potential changes in control as the major shareholder is planning a share transfer [12] - Qianli Technology reported a 63.44% year-on-year increase in automobile sales for November, although new energy vehicle sales decreased by 43.98% [13] Group 5 - Fosun Pharma's innovative drug FXS0887 has received approval for a Phase I clinical trial for advanced malignant solid tumors [14] - Guoen Co. has obtained approval for a project to produce 20,000 square meters of aviation-grade acrylic glass, with a total investment of 560 million yuan [15] - Guofa Co.'s chairman resigned due to personal reasons [17] Group 6 - Shanghai Construction won a bid for a state-owned construction land use right for 264 million yuan [18] - Weixin Kang's subsidiary received approval for a clinical trial of lidocaine cream for local anesthesia [20] - Sanxing Medical's subsidiary is a candidate for a 152 million yuan transformer procurement project for the State Grid [20] Group 7 - People's Daily announced the resignation of its president due to work changes, while retaining other leadership roles [21] - Beibu Gulf Port reported a 0.29% year-on-year increase in cargo throughput for November [22] - Chongqing Construction won three engineering projects with a total value of approximately 2.773 billion yuan [23] Group 8 - Xingyu Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange [24] - Huajian Group signed a design contract worth 160 million yuan for a comprehensive project [25] - Wankai New Materials plans to invest 350 million yuan in a technical transformation project for producing 100,000 tons of adipic acid [26] Group 9 - Kaipuyun received a government subsidy of 18 million yuan, which is 87.43% of its net profit for the last audited fiscal year [28] - Ningbo Port expects a 10.8% year-on-year increase in container throughput for November [30] - An Cai High-Tech plans to invest 498 million yuan to upgrade its photovoltaic glass production line [32] Group 10 - Shunhao Co. stated that its existing business has not generated synergies with the rail business, which faces various risks [34] - Yihualu plans to publicly transfer 35% of its stake in Liaoyun Company [35] - ST Wanfang's shareholder plans to reduce holdings by no more than 3% of the company's shares [36] Group 11 - Youyou Food's shareholder plans to reduce holdings by no more than 110,000 shares [38] - Hengtong Optic-Electric's incentive fund has spent 49.98 million yuan to purchase company shares [41] - Zoli Pharmaceutical plans to issue convertible bonds to raise no more than 1.556 billion yuan for various projects [42]

云天化（600096）(600096.SH)发布公告，公司全资子公司云南磷化集团有限公司经自查，2022年— 2025年10月应补缴资源税2.93亿元，滞纳金9264.55万元，总计3.86亿元。上述补缴税款及滞纳金将计入 公司2025年当期损益，预计减少公司2025年度归属于上市公司股东的净利润3.42亿元。 ...

智通财经APP讯，云天化(600096.SH)发布公告，公司全资子公司云南磷化集团有限公司经自查，2022 年—2025年10月应补缴资源税2.93亿元，滞纳金9264.55万元，总计3.86亿元。上述补缴税款及滞纳金将 计入公司2025年当期损益，预计减少公司2025年度归属于上市公司股东的净利润3.42亿元。 ...

二、对公司的影响及风险提示 根据《企业会计准则第 28 号—会计政策、会计估计变更和差错 更正》相关规定，上述补缴税款及滞纳金事项不属于前期会计差错， 不涉及前期财务数据追溯调整。上述补缴税款及滞纳金将计入公司 2025 年当期损益，预计减少公司 2025 年度归属于上市公司股东的净 利润 34,205.40 万元，最终以 2025 年度经审计的财务报表为准。 本次补缴税款事项不会影响公司的正常经营，敬请广大投资者注 意投资风险。 特此公告。 证券代码：600096 证券简称：云天化 公告编号：临 2025-079 云南云天化股份有限公司 关于子公司补缴税款的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 云南云天化股份有限公司（以下简称"公司"）全资子公司云南 磷化集团有限公司近期根据税务部门的要求，对涉税事项展开自查， 现将有关情况公告如下： 一、基本情况 公司全资子公司云南磷化集团有限公司经自查，2022 年—2025 年 10 月应补缴资源税 29,342.17 万元，滞纳金 9,264.55 万元，总计 38, ...

Core Viewpoint - Yuntianhua (600096.SH) announced that its wholly-owned subsidiary, Yunnan Phosphate Group Co., Ltd., has identified a total tax liability of 383.07 million yuan for resource tax and late fees from 2022 to October 2025 [1] Group 1 - The company is required to pay 293.42 million yuan in resource tax [1] - The late fees amount to 92.65 million yuan [1] - The total amount due is 386.07 million yuan [1]

Core Insights - The article discusses the growth of China's phosphate rock industry, highlighting a significant increase in production and future market potential [1] Industry Overview - According to the National Bureau of Statistics, China's phosphate rock production (calculated as P2O5 content of 30%) reached 13.06 million tons in September 2025, representing a year-on-year growth of 13.2% [1] - Cumulative production from January to September 2025 was 93.132 million tons, with a cumulative growth of 12.5% [1] Market Research - The report titled "2025-2031 China Phosphate Rock Industry Market Competition Strategy and Future Development Potential" by Zhiyan Consulting provides insights into the competitive strategies and growth potential of the phosphate rock market in China [1] - Zhiyan Consulting is recognized as a leading industry consulting firm in China, specializing in in-depth industry research reports, business plans, feasibility studies, and customized services [1]

Core Viewpoint - The report highlights the growth in China's agricultural nitrogen, phosphorus, and potassium fertilizer production, indicating a positive trend in the industry from 2020 to 2025 [1] Group 1: Industry Overview - In September 2025, China's agricultural nitrogen, phosphorus, and potassium fertilizer (calculated as pure) production reached 5.22 million tons, reflecting a year-on-year increase of 3.3% [1] - From January to September 2025, the cumulative production of agricultural nitrogen, phosphorus, and potassium fertilizers in China was 48.713 million tons, showing a cumulative growth of 9.6% [1] - The data is sourced from the National Bureau of Statistics and compiled by Zhiyan Consulting, a leading industry consulting firm in China [1] Group 2: Companies Involved - Listed companies in the fertilizer sector include Salt Lake Co. (000792), Hubei Yihua (000422), Yuntianhua (600096), Luxi Chemical (000830), Xinyangfeng (000902), Stanley (002588), Sichuan Meifeng (000731), and Yangmei Chemical (600691) [1]

Core Viewpoint - The chemical industry is currently experiencing a dual bottom in valuation and profitability, with signs of recovery in profit margins and a potential upward trend in the economic cycle driven by demand recovery and resource supply contraction [1][2]. Group 1: Industry Performance - As of December 3, 2025, the chemical sector index rose by 0.87%, with notable gains from stocks such as Hangzhou Oxygen Plant (up 4.48%) and Yara International (up 4.42%) [1]. - The basic chemical sector's net profit increased by 7.45% year-on-year for the first three quarters of 2025, indicating a recovery trend despite mixed performance across sub-sectors [1]. - The overall chemical industry remains at a low level of prosperity, but a gradual improvement in profit margins is becoming evident [1]. Group 2: Market Dynamics - The industry is expected to benefit from reduced supply-side pressures and a global monetary easing environment, particularly with the anticipated interest rate cuts by the Federal Reserve, which could stimulate downstream demand [1]. - The focus on "anti-involution" policies is crucial as multiple sub-industries face competitive pressures, and the industry is likely to accelerate the release of high-performance new materials driven by AI demand [1][2]. Group 3: Investment Opportunities - Investors can track the chemical sector through the Jia Shi Chemical ETF (159129), which closely follows the China Securities Index for the chemical industry [2]. - There are also opportunities for off-market investors to engage with the chemical sector via the Chemical ETF Connect Fund (013527) [3].

Summary of Phosphate Chemical Industry Conference Call Industry Overview - The domestic phosphate chemical industry is divided into two main pathways: thermal and wet processes. The thermal process produces high-purity phosphates and organic phosphorus products, while the wet process focuses on fertilizers and fine chemical products. Each has its advantages and disadvantages [1][3][4] - China accounts for over 40% of global phosphate rock production, but supply is constrained due to mining policies [1][4] Supply and Demand Dynamics - New phosphate rock capacity is expected to reach approximately 7.75 million tons in 2025, with planned capacity potentially reaching 28-29 million tons in 2026. However, actual release may only be around 20 million tons due to policy restrictions and the exit of old mines [1][4][5] - By 2027, an additional capacity of about 40 million tons is anticipated, but overall supply will be limited by policy constraints and the retirement of older mines [5][6] - Phosphate rock prices have stabilized around 1,000 RMB/ton this year, with expectations for a steady upward trend in the future, although there may be short-term fluctuations [1][5][7] Key Products and Applications - The phosphate fertilizer sector primarily revolves around traditional products such as monoammonium phosphate (MAP) and diammonium phosphate (DAP), which are crucial for agricultural production. Domestic phosphate fertilizer production is around 25 million tons, with exports managed through quotas and structural controls [1][8][9] - Glyphosate prices surged to approximately 27,000 RMB/ton in Q2 2025, with potential to reach 30,000 RMB/ton in the next 1-2 months, benefiting from the pesticide inventory cycle. Xingfa Group has a nominal capacity of 230,000 tons for glyphosate, indicating significant growth potential [1][10][11] Market Outlook - The phosphate chemical industry is expected to enter a relatively long boom cycle starting in 2026, driven by resource investment opportunities. Key companies to watch include Xingfa Group, Yuntianhua, and Chuanjinnuo [2][14] - The lithium iron phosphate market has seen significant capacity release since 2021, with total domestic capacity around 5.2 million tons. Demand from energy storage and power batteries is expected to drive an additional 1 million tons of phosphate rock demand [12][14] Company Insights - Xingfa Group's glyphosate production could yield nearly 1 billion RMB in profit if prices reach 30,000 RMB/ton. The company also plans to increase its raw ore capacity from 5.85 million tons to 10-11 million tons, which could enhance performance if phosphate rock prices rise in 2026 [13][14] - Yuntianhua is positioned as a leading phosphate chemical enterprise in Yunnan, while Chuanjinnuo shows growth potential in its salt chemical project in Egypt [13][14] Conclusion - The phosphate chemical industry is poised for growth, with stable demand for fertilizers and potential price increases for glyphosate. Companies with strong market positions and growth strategies are likely to benefit significantly in the coming years [2][14]